论文部分内容阅读
目的:研究胺碘酮在治疗快速室上性心律失常中的应用效果,总结其临床应用价值。方法:选取我院2009年1月—2011年1月收治的60例病情发作到就诊时间在48小时内的急诊患者,将其随机分成观察组(30例)与对照组(30例),观察组使用胺碘酮,对照组使用心律平,将两组患者的临床治疗效果和不良反应进行对比。结果:观察组有不良反应症状的患者为2例,发生率为9.5%,对照组有不良反应症状的患者为6例,发生率为28.5%,两组比较,存在明显差异(P<0.05),具有统计学意义。结论:胺碘酮在治疗快速室上性心律失常中的效果非常明显,能快速缓解症状,且药物不良反应少,安全性高,值得临床推广。
Objective: To study the effect of amiodarone in the treatment of rapid supraventricular arrhythmias and to summarize its clinical value. Methods: From January 2009 to January 2011 in our hospital, 60 patients were selected and divided into observation group (30 cases) and control group (30 cases) with emergency treatment within 48 hours after treatment. Group using amiodarone, the control group using the heart rate, the two groups of patients with clinical treatment and adverse reactions were compared. Results: In the observation group, there were 2 patients with adverse reaction symptoms, the incidence rate was 9.5%, 6 patients with adverse reaction symptoms in the control group, the incidence rate was 28.5%. There was significant difference between the two groups (P <0.05) ,has statistical significane. Conclusion: The effect of amiodarone in the treatment of rapid supraventricular arrhythmias is very obvious, can quickly relieve symptoms, and less adverse drug reactions, high safety, worthy of clinical promotion.